India news

Sangwan banned for 18 months

ESPNcricinfo staff

October 19, 2013

Comments: 1 | Text size: A | A

Pradeep Sangwan fires one in, India v South Africa, Under-19 World Cup final, Kuala Lumpur, March 2, 2008
Pradeep Sangwan's ban period has already commenced from May 2013 © Getty Images
Enlarge
Related Links
News : Pradeep Sangwan fails dope test
Players/Officials: Pradeep Sangwan
Teams: India

Pradeep Sangwan, the Delhi and Kolkata Knight Riders seamer, has been banned for a period of 18 months from taking part in any BCCI-run event for violating the anti-doping regulations during IPL 2013. The BCCI-appointed anti-doping panel found that Sangwan's sample showed the presence of stanozolol, a prohibited steroid.

Sangwan's ineligibility period has already commenced, from May 6 2013, and will expire on November 5, 2014. The seamer had failed a random dope test conducted during IPL 2013.

AN Sharma, Sangwan's first coach, had said in July this year, the problem could have arisen due to treatment Sangwan was receiving for a shoulder problem. "Since he had no time to consult or visit the BCCI doctor, he saw a local doctor, who gave him an injection," he had said then. "There was instant relief from the pain thereafter and he also managed to play the IPL." But Sharma had reiterated that players should be careful about such treatments.

Random tests are conducted during the IPL, like in ICC tournaments. The BCCI, which doesn't come under the WADA (World Anti-Doping Agency) or the NADA (National Anti-Doping Agency), follow their own anti-doping procedures.

Sangwan, 22, played only two matches for Knight Riders this season and failed to pick up a wicket. He made his first-class debut in 2007 and has played 38 matches for Delhi.

© ESPN Sports Media Ltd.

Posted by IndCricFan2013 on (October 19, 2013, 16:42 GMT)

22 years old, what kind of guidance was given by BCCI to these players???

Comments have now been closed for this article

TopTop
Email Feedback Print
Share
E-mail
Feedback
Print
ESPNcricinfo staffClose
News | Features Last 3 days
News | Features Last 3 days